- Home
- CADL vs HRZN Comparison
CADL vs HRZN Comparison
Compare CADL & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- HRZN
- Stock Information
- Founded
- CADL 1999
- HRZN 2008
- Country
- CADL United States
- HRZN United States
- Employees
- CADL N/A
- HRZN N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- HRZN Finance/Investors Services
- Sector
- CADL Health Care
- HRZN Finance
- Exchange
- CADL Nasdaq
- HRZN Nasdaq
- Market Cap
- CADL 313.5M
- HRZN 295.3M
- IPO Year
- CADL 2021
- HRZN 2010
- Fundamental
- Price
- CADL $4.84
- HRZN $6.63
- Analyst Decision
- CADL Strong Buy
- HRZN Hold
- Analyst Count
- CADL 5
- HRZN 4
- Target Price
- CADL $19.80
- HRZN $7.81
- AVG Volume (30 Days)
- CADL 697.1K
- HRZN 641.6K
- Earning Date
- CADL 11-13-2025
- HRZN 10-28-2025
- Dividend Yield
- CADL N/A
- HRZN 19.89%
- EPS Growth
- CADL N/A
- HRZN N/A
- EPS
- CADL N/A
- HRZN N/A
- Revenue
- CADL N/A
- HRZN $97,144,000.00
- Revenue This Year
- CADL N/A
- HRZN N/A
- Revenue Next Year
- CADL N/A
- HRZN $9.61
- P/E Ratio
- CADL N/A
- HRZN N/A
- Revenue Growth
- CADL N/A
- HRZN N/A
- 52 Week Low
- CADL $3.79
- HRZN $6.56
- 52 Week High
- CADL $14.60
- HRZN $11.08
- Technical
- Relative Strength Index (RSI)
- CADL 34.62
- HRZN 28.94
- Support Level
- CADL $4.60
- HRZN $6.79
- Resistance Level
- CADL $5.01
- HRZN $6.97
- Average True Range (ATR)
- CADL 0.29
- HRZN 0.12
- MACD
- CADL -0.04
- HRZN 0.00
- Stochastic Oscillator
- CADL 15.28
- HRZN 13.73
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.